Totals
- Total revenue
- $355,798,320
- Total expenses
- $439,138,919
- Contributions and grants received
- $95,892,260
- Grants paid
- $202,017,166
- Program service revenue
- $3,272,736
- Investment income
- $231,324,892
- Other revenue
- $25,308,432
- Total assets, end of year
- $4,986,222,387
- Total liabilities, end of year
- $292,597,881
- Net assets or fund balances, end of year
- $4,693,624,506
- Program services expenses (Part IX)
- $346,709,365
- Management and general expenses
- $57,319,385
- Fundraising expenses
- $35,110,169
- Program service expenses (Part III)
- $346,709,366
Program services were 79.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Listed in Part VII
-
MICHAEL P BOYLE MD
PRESIDENT & CEO
- Total calculated
- $1,275,151
- From this org
- $1,054,388
- From related orgs
- $0
- Other
- $220,763
- Hours/week
- 40 + 1 related
Schedule J breakdown matched by us
- Base
- $721,173
- Bonus
- $311,579
- Other
- $21,636
- Deferred
- $163,962
- Nontaxable benefits
- $56,801
- Filer's total
- $1,275,151
-
CAROLE B GRIEGO MD
TRUSTEE
- Total calculated
- $0
- Hours/week
- 3
-
DAVID A MOUNT
TREASURER
- Total calculated
- $0
- Hours/week
- 5
-
DODZIE SOGAH PHD
TRUSTEE
- Total calculated
- $0
- Hours/week
- 3
-
DOMINIC J CARUSO
TRUSTEE
- Total calculated
- $0
- Hours/week
- 3
-
ELISE EBERWEIN
TRUSTEE
- Total calculated
- $0
- Hours/week
- 3
-
ERIC R OLSON PHD
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
ERIC SCHNEIDER MD
TRUSTEE
- Total calculated
- $0
- Hours/week
- 3
-
JESSICA H BOYD MD
TRUSTEE
- Total calculated
- $0
- Hours/week
- 3
-
JOHN S WEINBERG
EXECUTIVE VICE CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
KATE O'DONNELL
TRUSTEE
- Total calculated
- $0
- Hours/week
- 3
-
KC BRYAN WHITE
CHAIR
- Total calculated
- $0
- Hours/week
- 8
-
LOUIS A DEFALCO
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
PAUL A MOTENKO
TRUSTEE
- Total calculated
- $0
- Hours/week
- 3
-
ROBERT H NIEHAUS
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
STEVEN SHAK MD
TRUSTEE
- Total calculated
- $0
- Hours/week
- 3
-
TERESA L ELDER
VICE CHAIR
- Total calculated
- $0
- Hours/week
- 5
-
IRENA BARISIC
EVP & CHIEF OPERATING & FINANCIAL OFFICER
- Total calculated
- $844,555
- From this org
- $761,939
- From related orgs
- $0
- Other
- $82,616
- Hours/week
- 40 + 1 related
Schedule J breakdown matched by us
- Base
- $610,580
- Bonus
- $150,219
- Other
- $1,140
- Deferred
- $80,370
- Nontaxable benefits
- $2,246
- Filer's total
- $844,555
-
MICHAEL B CAVADEL
SVP, CHIEF LEGAL OFFICER
- Total calculated
- $661,197
- From this org
- $558,135
- From related orgs
- $0
- Other
- $103,062
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $470,090
- Bonus
- $86,964
- Other
- $1,081
- Deferred
- $65,989
- Nontaxable benefits
- $37,073
- Filer's total
- $661,197
-
ALBERT FARO MD
Chief Medical Officer Beg. 7/1/2024
- Total calculated
- $671,590
- From this org
- $571,672
- From related orgs
- $0
- Other
- $99,918
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $480,427
- Bonus
- $83,943
- Other
- $7,302
- Deferred
- $37,474
- Nontaxable benefits
- $62,444
- Filer's total
- $671,590
-
BRUCE MARSHALL MD
Chief Medical Officer Ending 7/1/2024
- Total calculated
- $550,128
- From this org
- $515,472
- From related orgs
- $0
- Other
- $34,656
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $359,859
- Bonus
- $150,051
- Other
- $5,562
- Deferred
- $34,656
- Nontaxable benefits
- $0
- Filer's total
- $550,128
-
JOHN C MAHLER JR MD
CHIEF INVESTMENT OFFICER
- Total calculated
- $1,942,627
- From this org
- $1,866,868
- From related orgs
- $0
- Other
- $75,759
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $766,301
- Bonus
- $1,091,398
- Other
- $9,169
- Deferred
- $34,656
- Nontaxable benefits
- $41,103
- Filer's total
- $1,942,627
-
JOHN P CLANCY MD
SVP, CLINICAL RESEARCH
- Total calculated
- $765,204
- From this org
- $669,826
- From related orgs
- $0
- Other
- $95,378
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $523,667
- Bonus
- $138,635
- Other
- $7,524
- Deferred
- $41,817
- Nontaxable benefits
- $53,561
- Filer's total
- $765,204
-
STEVEn ROWE MD
EVP, Chief Scientific Officer
- Total calculated
- $667,206
- From this org
- $534,655
- From related orgs
- $0
- Other
- $132,551
- Hours/week
- 32
Schedule J breakdown matched by us
- Base
- $438,558
- Bonus
- $93,679
- Other
- $2,418
- Deferred
- $78,210
- Nontaxable benefits
- $54,341
- Filer's total
- $667,206
-
ANDREW LEWIS
MANAGING DIRECTOR, INVESTMENTS
- Total calculated
- $1,401,714
- From this org
- $1,363,454
- From related orgs
- $0
- Other
- $38,260
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $469,402
- Bonus
- $891,950
- Other
- $2,102
- Deferred
- $20,856
- Nontaxable benefits
- $17,404
- Filer's total
- $1,401,714
-
EARL A LEE
MANAGING DIRECTOR, INVESTMENTS
- Total calculated
- $1,594,752
- From this org
- $1,226,269
- From related orgs
- $0
- Other
- $368,483
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $665,920
- Bonus
- $558,525
- Other
- $1,824
- Deferred
- $349,255
- Nontaxable benefits
- $19,228
- Filer's total
- $1,594,752
-
ENRIQUE LIN SHIAO PHD
Principal of Mission Related Investments
- Total calculated
- $589,642
- From this org
- $507,691
- From related orgs
- $0
- Other
- $81,951
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $241,850
- Bonus
- $265,203
- Other
- $638
- Deferred
- $34,656
- Nontaxable benefits
- $47,295
- Filer's total
- $589,642
-
ERIC KOEHRSEN
MANAGING DIRECTOR, INVESTMENTS
- Total calculated
- $1,280,707
- From this org
- $976,105
- From related orgs
- $0
- Other
- $304,602
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $600,659
- Bonus
- $374,293
- Other
- $1,153
- Deferred
- $248,801
- Nontaxable benefits
- $55,801
- Filer's total
- $1,280,707
-
GENTIANA S AROVAS
MANAGING DIRECTOR, INVESTMENTS OPERATIONS
- Total calculated
- $819,659
- From this org
- $642,532
- From related orgs
- $0
- Other
- $177,127
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $478,673
- Bonus
- $161,598
- Other
- $2,261
- Deferred
- $122,786
- Nontaxable benefits
- $54,341
- Filer's total
- $819,659
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Independent compensation consultant
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
- 4b · Supplemental nonqualified retirement plan
- 5a · Pay contingent on this organization's revenues
- 7 · Other non-fixed payments
Answered no
- 4a · Severance or change-of-control payment
- 4c · Equity-based compensation arrangement
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 8 · Paid under the initial-contract exception
The filer's explanations (Part III)
- Schedule J, Part I, Line 4b Supplemental nonqualified retirement plan
- THE EXECUTIVE LISTED BELOW PARTICIPATED IN A NONQUALIFIED DEFERRED COMPENSATION PLAN, UNDER WHICH INTERESTS ARE FORFEITED BY THE PARTICIPANT IF THE PARTICIPANT VOLUNTARILY TERMINATES EMPLOYMENT PRIOR TO THE DESIGNATED VESTING DATE. TOTAL PAYMENTS MADE BY THE PLAN TO THE EXECUTIVE DURING THE REPORTING YEAR IS PROVIDED BELOW: NAME: MICHAEL P. BOYLE, M.D. AMOUNT: $14,112
- Schedule J, Part I, Line 5a Compensation contingent on revenues of the organization
- The CF Foundation Investments Department Incentive Compensation and Retention Plan provides annual cash incentives to the CIO and certain Investment department staff, based on both quantitative and qualitative performance. For eligible staff, a portion is deferred and vests after three years, accruing interest tied to portfolio returns during the deferral period. Awards may be forfeited or paid pro-rata upon death, disability, or separation from service.
- Schedule J, Part I, Line 7 Non-fixed payments
- SEVERAL INDIVIDUALS LISTED IN FORM 990, PART VII, SECTION A, LINE 1A, PARTICIPATED IN THE CF FOUNDATION'S INCENTIVE COMPENSATION PLAN, FROM WHICH NON-FIXED PAYMENTS NOT DESCRIBED IN LINES 5 AND 6 WERE PAID. THE INCENTIVE COMPENSATION PLAN MAKES NON-FIXED PAYMENTS SUBJECT TO, AND BASED ON the achievement of long-term performance objectives established in ADVANCE BY THE COMPENSATION COMMITTEE OF THE CF FOUNDATION'S BOARD OF TRUSTEES. IN ADDITION, THE INCENTIVE COMPENSATION PLAN PAYS NON-FIXED PAYMENTS THAT RELATE TO A THREE-YEAR PERFORMANCE PERIOD, SUBJECT TO, AND BASED ON, ADVANCE BY THE COMPENSATION COMMITTEE OF THE BOARD. ANY FINANCIAL PLAN DO NOT INCLUDE PROGRAM RELATED REVENUES SUCH AS ROYALTY STREAMS OR LUMP-SUM PAYMENTS, RELATED TO THE DEVELOPMENT AND APPROVAL OF CF DRUGS.
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$12,893,328
CLINICAL RESEARCH STUDY
-
$10,180,397
CLINICAL RESEARCH CENTER
-
CLINICAL RESEARCH STUDY
-
$5,459,200
CLINICAL RESEARCH
-
Trustees of Indiana University
$4,014,448
CLINICAL RESEARCH STUDY
-
$3,000,000
Patient Assistance
-
University of Alabama at Birmingham
$2,962,497
RESEARCH
-
Case Western Reserve University
$2,183,802
RESEARCH
-
$2,155,537
CLINICAL RESEARCH STUDY
-
$2,053,746
THERAPEUTICS DISCOVERY RESEARCH
The 10 largest by cash amount. The API serves every itemized grant.
Related organizations on this return
Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.
-
CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC
501(c)(3) · RESEARCH · MD · controlled entity
Directly controlled by CFF
Taxable family on this return
Schedule R Parts I, III and IV, as filed. These record ownership and control, not shared board members or money moved.
Disregarded entities
Part I: entities that legally are the filer and file no return of their own.
-
Oaktree QR CLV LP
Investments · DE · income $251,866 · assets $13,751,866
Directly controlled by Cystic Fibrosis Foundation
Related partnerships
Part III: related organizations taxable as a partnership, with the filer's share.
-
AXAR QR OPPORTUNISTIC CREDIT FUND LP
Excluded · INVESTMENTS · DE · 92.141% owned · share of income $838,845 · share of assets $22,761,571
-
Excluded · INVESTMENTS · DE · 100% owned · share of income -$641,159 · share of assets $31,178
-
Excluded · INVESTMENTS · DE · 100% owned · share of income -$1,686,725 · share of assets $14,780,680
Related corporations and trusts
Part IV: related organizations taxable as a corporation or trust.
-
CHARITABLE REMAINDER TRUST (2)
Trust · FIDUCIARY · CA
Directly controlled by NA
-
CHARITABLE REMAINDER TRUST
Trust · FIDUCIARY · TN
Directly controlled by NA
-
CHARITABLE REMAINDER TRUST
Trust · FIDUCIARY · NM
Directly controlled by NA
-
PERPETUAL TRUST
Trust · FIDUCIARY · MA
Directly controlled by NA
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 14 November 2025
- IRS schema version
- 2024v5.1
- Source object
- 202533189349311948
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.